TOSOUT LC is an oral syrup containing levodropropizine 30 mg and chlorpheniramine maleate 2 mg per 5 mL. Levodropropizine is a peripheral antitussive; chlorpheniramine maleate is a first-generation H1 antihistamine. These ingredients have distinct pharmacological roles in cough and allergic symptoms. The formulation is described as ice-cream flavoured and supplied in a 100 mL bottle. Use of this fixed-dose combination should be guided by clinical assessment and the approved product labeling, including consideration of its suitability for the individual patient.
Verified product information, formulation specifications, and commercial supply pathways for registered healthcare professionals, institutions, and trade partners.
Review verified active composition, strength, dosage form, and packaging details on this page.
View SpecificationsRequest formulation literature, technical specifications, or product communication from our commercial team.
Submit Product EnquiryConnect regarding institutional supply requirements, trade distribution, or third-party contract manufacturing.
Commercial EnquiryThis product information is intended for registered healthcare professionals, medical practitioners, and authorized distribution partners. Product manufacturing is coordinated through eligible facility partners under applicable licences.
Request information about TOSOUT LC for professional use.